Company Number: SC753811

Analysis Date: 2025-07-29 20:51 UTC

1. Credit Opinion: DECLINE
   Aestheticon Limited is a micro-entity incorporated recently (Dec 2022) with minimal trading history and unaudited accounts for its first full financial year ending Dec 2023. The company shows net current liabilities of £326 and negative net assets, indicating an immediate working capital deficiency and weak balance sheet. Such financial position suggests the company currently lacks the capacity to service debt or absorb financial shocks. Combined with a single employee and no profit or cash flow data available, the risk of default is high. Until the company demonstrates improved profitability, positive net assets, and stable cash flows, credit approval is not recommended.

2. Financial Strength:
   The balance sheet shows total current assets of £2,142 against current liabilities of £2,468, resulting in a net current liability position of £326. No fixed assets are reported. The negative shareholders’ funds reflect accumulated losses or initial undercapitalization. The company is financially fragile with inadequate liquidity and no equity buffer, which limits its ability to fund operations or repay creditors without external support.

3. Cash Flow Assessment:
   No detailed cash flow statement is provided, but the net current liability position implies constrained liquidity. With minimal assets and working capital deficit, the company likely faces cash flow pressure to meet short-term obligations. The absence of profit and retained earnings data further limits insight into operational cash generation capacity. This lack of liquidity is a concern for loan repayment or managing supplier credit terms.

4. Monitoring Points:

• Improvement in net current assets and movement to positive working capital
• Evidence of profitability or positive retained earnings in subsequent filings
• Cash flow generation and management of creditors vs debtors
• Stability and continuity of key management/directors, especially given recent changes in director appointments
• Compliance with filing deadlines and any changes in company status or control